IL57513A0 - 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL57513A0
IL57513A0 IL57513A IL5751379A IL57513A0 IL 57513 A0 IL57513 A0 IL 57513A0 IL 57513 A IL57513 A IL 57513A IL 5751379 A IL5751379 A IL 5751379A IL 57513 A0 IL57513 A0 IL 57513A0
Authority
IL
Israel
Prior art keywords
diaminopropan
ols
benzoyl
phenyl
preparation
Prior art date
Application number
IL57513A
Other languages
English (en)
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of IL57513A0 publication Critical patent/IL57513A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrrole Compounds (AREA)
IL57513A 1978-06-24 1979-06-07 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them IL57513A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782827801 DE2827801A1 (de) 1978-06-24 1978-06-24 Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel

Publications (1)

Publication Number Publication Date
IL57513A0 true IL57513A0 (en) 1979-10-31

Family

ID=6042666

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57513A IL57513A0 (en) 1978-06-24 1979-06-07 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US4271193A (xx)
EP (1) EP0006458B1 (xx)
JP (1) JPS554397A (xx)
AT (1) ATE270T1 (xx)
AU (1) AU4831279A (xx)
DE (2) DE2827801A1 (xx)
DK (1) DK263579A (xx)
ES (1) ES481792A1 (xx)
FI (1) FI791976A (xx)
HU (1) HU179996B (xx)
IL (1) IL57513A0 (xx)
NO (1) NO792105L (xx)
PT (1) PT69808A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198352A (en) 1978-11-29 1980-04-15 Shell Oil Company Internal olefin hydroformylation process
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
WO2005095327A1 (ja) * 2004-03-31 2005-10-13 Ajinomoto Co., Inc. アニリン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
DE2720908A1 (de) * 1977-05-10 1978-11-23 Kali Chemie Pharma Gmbh Arzneimittel mit ulkustherapeutischem effekt
DE2720968C2 (de) * 1977-05-10 1986-05-07 Kali-Chemie Pharma Gmbh, 3000 Hannover N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel

Also Published As

Publication number Publication date
ES481792A1 (es) 1980-07-01
DK263579A (da) 1979-12-25
AU4831279A (en) 1980-01-03
FI791976A (fi) 1979-12-25
JPS554397A (en) 1980-01-12
DE2960927D1 (en) 1981-12-17
US4271193A (en) 1981-06-02
JPS6245858B2 (xx) 1987-09-29
DE2827801A1 (de) 1980-01-10
EP0006458A1 (de) 1980-01-09
ATE270T1 (de) 1981-10-15
HU179996B (en) 1983-01-28
NO792105L (no) 1979-12-28
EP0006458B1 (de) 1981-10-07
PT69808A (en) 1979-07-01

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
AU678344B2 (en) Lipophilic oligosaccharide antibiotic salt compositions
DK0516941T3 (da) Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling deraf
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
DE3269241D1 (en) Triazoloquinazolines, process for their preparation and pharmaceutical compositions containing them
AU530678B2 (en) Phosphono-hydroxy-acetic acid
IL57513A0 (en) 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
IT1248525B (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.